1. Anal intraepithelial neoplasia and squamous cell carcinoma in HIV‐infected adults. Issue 2 (6th September 2013) Authors: Tong, WWY; Hillman, RJ; Kelleher, AD; Grulich, AE; Carr, A Journal: HIV medicine Issue: Volume 15:Issue 2(2014:Feb.) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P10.10 T-cells in the anal mucosa of men with high-grade squamous intraepithelial lesions. (13th September 2015) Authors: Tong, WWY; Turville, S; Roberts, J; Zaunders, J; Jin, F; Poynten, IM; Hillman, RJ; Grulich, AE; Kelleher, AD; Carr, A Journal: Sexually transmitted infections Issue: Volume 91(2015)Supplement 2 Page Start: A168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Raltegravir‐emtricitabine‐tenofovir as HIV nonoccupational post‐exposure prophylaxis in men who have sex with men: safety, tolerability and adherence1. Issue 1 (6th September 2013) Authors: McAllister, J; Read, P; McNulty, A; Tong, WWY; Ingersoll, A; Carr, A Journal: HIV medicine Issue: Volume 15:Issue 1(2014:Jan.) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks1. Issue 6 (26th January 2014) Authors: Bloch, M; Tong, WWY; Hoy, J; Baker, D; Lee, FJ; Richardson, R; Carr, A; TROP (Switch from Tenofovir to Raltegravir for Low Bone Density) study team Journal: HIV medicine Issue: Volume 15:Issue 6(2014:Jul.) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗